About Anagenex
Founded in 2019, we are a biotechnology company that discovers new medicines by combining ultra throughput biochemistry and machine learning.
Team & Culture
We are a growing team of 11-50 employees.
Frequently Asked Questions
Anagenex focuses on discovering new medicines through the combination of ultra throughput biochemistry and machine learning.
Anagenex was founded in 2019.
Anagenex has 11-50 employees.
Anagenex hires globally with a remote-first approach, allowing employees to work from anywhere.
Anagenex is not actively hiring at the moment. Check back later for new opportunities.
Yes, Anagenex is a remote-first company.
Anagenex's website is www.anagenex.com .
You can find Anagenex on LinkedIn .
Remote companies like Anagenex
Explore remote-first companies similar to Anagenex. Discover other top-rated employers that offer flexible schedules and work-from-anywhere options.

ília
Creates digital products and solutions using technology, design, and data for financial services, insurance, mobility, and health sectors.

Jobscan
Helps job seekers optimize resumes and LinkedIn profiles using AI to improve interview chances.

AdTheorent
Delivers advertising campaigns using advanced machine learning and privacy-forward solutions.

Reply
Digital services, technology, and consulting with solutions for new communication channels and digital media.

Ultima Genomics
Developing DNA sequencing platforms for high-throughput, cost-effective genomic information.

GRAPH AWARE LIMITED
Develops intelligence analysis software using graph technology to unify data for various organizations.
Project: Career Search
Rev. 2026.2
[ Remote Jobs ]
Direct Access
We source jobs directly from 21,000+ company career pages. No intermediaries.
Discover Hidden Jobs
Unique jobs you won't find on other job boards.
Advanced Filters
Filter by category, benefits, seniority, and more.
Priority Job Alerts
Get timely alerts for new job openings every day.
Manage Your Job Hunt
Save jobs you like and keep a simple list of your applications.
